Investor Relations

Event Details

2022 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING

Jun 3 - Jun 7, 2022

Poster Details are as follows:
Title: A First-in-Human, Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-Tumor Activity of Neoadjuvant Use of PH-762 Administered Intratumorally in Subjects with Advanced Melanoma Author: Professor Caroline Robert, M.D., Ph.D., Head of the Dermatology Unit at Gustave Roussy and co-director of the Melanoma Research Unit at INSERM 981 Paris-Sud University
Abstract Number: TPS9608 Session: Melanoma/Skin Cancers
Date and Time: June 6, 2022 at 1:15 – 4:15 p.m. Central Time